Cell processing involves collecting, separating, modifying, cultivating, washing, and preparing cells for research or therapeutic applications. Because cells are sensitive to environmental conditions and contamination, processing methods must maintain appropriate levels of sterility and product integrity. Traditional open processing may expose materials to the surrounding environment during certain operations, increasing the need for carefully controlled facilities and procedures. Closed system technologies address these challenges by using enclosed equipment and sterile connections to limit direct environmental exposure. They are increasingly relevant in advanced therapy manufacturing, including processes used to develop cellular immunotherapies and regenerative medicine products.
A closed processing system is designed to prevent the direct exposure of processed materials to the external environment during defined operations. Depending on the equipment and process design, cells can move between containers, tubing assemblies, processing chambers, and storage bags without being directly exposed to the surrounding workspace.
These systems may include single-use components, automated instruments, sterile connectors, and integrated fluid pathways. Their configuration depends on the type of cells being processed, the manufacturing scale, and the requirements of the intended application.
Important components and characteristics include:
Sterile tubing and connectors: These components facilitate the transfer of fluids and cellular materials while helping maintain the integrity of the processing pathway.
Single-use processing assemblies: Disposable bags, tubing sets, and containers can reduce the need for cleaning and revalidation between batches, although supplier controls and assembly integrity remain important.
Automated processing equipment: Automated systems can perform defined operations such as cell washing, concentration, separation, and media exchange with reduced manual handling.
Controlled transfer mechanisms: Sterile welding and specialized connectors can support transfers between compatible components without unnecessarily opening the processing pathway.
Monitoring and documentation: Process parameters, equipment performance, and handling records help establish traceability and support quality assurance.
A system is not automatically considered closed simply because it uses disposable equipment. Its classification depends on the design, the integrity of connections, the potential for contamination, and the conditions under which it operates. Manufacturers must assess these factors for the specific process.
Closed system technologies can help improve contamination control and support the development of consistent manufacturing workflows. By limiting direct exposure to the environment, they may reduce dependence on certain open manipulations and simplify some operational requirements. However, the benefits depend on system design, validation, and appropriate implementation.
Several considerations influence their use in cell processing:
Contamination control: Enclosed pathways can reduce opportunities for microbial or particulate contamination, but they do not eliminate all contamination risks.
Process consistency: Standardized equipment and automated operations can reduce variability associated with manual handling.
Facility requirements: Some closed processes may reduce the need for extensive cleanroom interventions, although facility controls must still reflect the product, process, and applicable regulations.
Scalability: Equipment must accommodate the required cell quantities, processing volumes, and manufacturing capacity without compromising product quality.
Compatibility: Tubing, bags, connectors, and processing instruments must be suitable for the biological material and the intended operating conditions.
Validation and training: Manufacturers need documented procedures, qualified equipment, trained personnel, and appropriate evidence that the system performs as intended.
Challenges may include equipment costs, compatibility limitations, complex process integration, and the need to validate connections and automated operations. Changes to consumables or processing configurations may also require formal evaluation.
Closed system technologies are an important part of modern cell processing because they can support controlled handling, reliable workflows, and product protection. Their effectiveness depends on selecting appropriate equipment, maintaining system integrity, and applying suitable quality controls. As cellular therapies and advanced biological manufacturing continue to develop, closed processing approaches remain relevant to efforts to improve process consistency and manage contamination risks.